item management s discussion and analysis of financial condition and results of operations management s discussion and analysis of financial condition and results of operations should be read in conjunction with the selected financial data and consolidated financial statements and notes thereto included elsewhere herein 
the company designs  manufactures and markets nasal cpap equipment for the diagnosis and treatment of obstructive sleep apnea 
the company s net revenues are generated from the sale of its various nasal cpap devices  nasal mask systems  accessories and other products  and  to a lesser extent from royalties 
the company receives other income through interest and certain australian government grants 
prior to  the company marketed its products in several countries primarily through independent distributors 
in may  the company terminated its united states distributor  and acquired certain inventory maintained by the distributor  employed four of the distributor s sales employees  and issued stock options to the distributor  which were subsequently repurchased by the company in october after such termination  the company established a direct sales force in the united states and developed a network of independent sales representatives 
in early  the company commenced in house manufacturing operations  consisting primarily of assembly activities  at its sydney  australia facility 
this facility was expanded in december and during fiscal the company has invested significant resources in research and development and product enhancement 
since  the company has developed several innovations to the original cpap device to increase patient comfort and to improve ease of product use 
the company has recently been developing products for automated treatment and monitoring of osa  such as autoset trademark 
the company s research and development expenses are subsidized in part by grants and tax incentives from the australian federal government 
the company has also received grants from the australian federal government to support marketing efforts to increase australian export sales  and for incorporation of computer components into its products 
given australian government regulations the company does not expect to receive future australian export sales grants 
the company s income tax rate is governed by the laws of the regions in which the company s income is recognized 
to date  a substantial portion of the company s income has been subject to income tax in australia where the statutory rate prior to june  was  increased to effective july  during fiscal  and  the company s effective tax rate has fluctuated from approximately to approximately 
these fluctuations have resulted from  and future effective tax rates will depend upon  numerous factors  including the amount of research and development expenditures for which a australian tax deduction is available  the level of non deductible expenses  and the use of available net operating loss carryforward deductions and other tax credits or benefits available to the company under applicable tax laws 
following is a comparative discussion by fiscal year of the results of operations for the three years ended june  fiscal year ended june  compared to fiscal year ended june  net revenues 
net revenues increased in fiscal to million from million in fiscal  an increase of million or 
this increase was primarily attributable to an increase in unit sales of the company s flow generators and accessories in europe where net revenues increased to million from million and  to a lesser extent  in north america  where net revenues increased to million from million 
in addition  net revenues were affected favorably by a product mix shift to new  higher priced products such as sullivan vpapii 
this favorable effect was partially offset by a decrease in the selling prices of the company s cpap products in most geographic markets 
gross profit 
gross profit increased in fiscal to million from million in  an increase of million or 
the increase resulted primarily from increased unit sales during fiscal gross profit as a percentage of net revenues declined in fiscal to from in the decrease was primarily due to an increase in the value of the australian dollar relative to the us dollar over the period and continuing price competition in the united states  where prices for the company s products are lower than elsewhere in the world 
the increased value of the australian dollar increases the relative cost of manufacturing in australia where the company s manufacturing facilities are located 
selling  general and administrative expenses 
selling  general and administrative expenses increased in to million from million for  an increase of million or 
as a percentage of net revenues  selling  general and administrative expenses increased in fiscal to from for fiscal the increase in expenses was due primarily to the acquisition of the company s german distributor in february  an increase to from in the number of sales and administrative personnel  and other expenses related to the increase in the company s sales 
in addition the company incurred substantial legal fees with respect to its ongoing patent action of  and  in and  respectively 
research and development expenses 
research and development expenses increased in fiscal to million from million in fiscal  an increase of approximately  or 
as a percentage of net revenues  research and development expenses in fiscal decreased to from in fiscal the dollar increase in research and development expenses was due primarily to an increase in research and development equipment and external consultancy fees 
other income 
other income increased in fiscal to million from  for fiscal  an increase of million or 
this increase was due primarily to the recognition of unrealized gains on foreign currency options of  as a result of marking the options to market which arose from revaluation of the australian dollar over the year  and million of interest income derived from funds generated from the company s june  initial public offering of common stock 
income taxes 
the company s effective income tax rate for fiscal increased to approximately from approximately for fiscal this increase was primarily due to the an increase in the australian income tax rate from to from july  and high relative taxes incurred in germany 
these higher tax rates were partially offset by additional research and development expenses in australia for which the company received a deduction for tax purposes 
fiscal years ended june  and june  net revenues 
net revenues increased in fiscal to million from million in fiscal  an increase of million or 
this increase was primarily attributable to an increase in unit sales of the company s flow generators and accessories in north america  where net revenues increased to million from million  and  to a lesser extent  in europe where net revenues increased to million from million 
in addition  net revenues were affected favorably by a product mix shift to new  higher priced products such as sullivan vpap 
this favorable effect was partially offset by a decrease in the selling prices of the company s products in most geographic markets 
gross profit 
gross profit increased in fiscal to million from million in  an increase of million or 
the increase resulted primarily from increased unit sales during fiscal gross profit as a percentage of net revenues declined in fiscal to from in the decrease was primarily due to an increasing percentage of the company s worldwide sales occurring in the united states  where prices for the company s products are lower than elsewhere in the world 
in addition  gross profit as a percentage of net revenues declined due to an increase in the value of the australian dollar relative to the united states dollar during the period 
this increased the relative cost of manufacturing which occurs in australia 
also contributing to the decrease was the introduction of a new lower margin humidifier manufactured by a third party for the company 
selling  general and administrative expenses 
selling general and administrative expenses increased in to million from million for  an increase of million or 
as a percentage of net revenues  selling  general and administrative expenses declined in fiscal to from for fiscal the increase in expenses was due primarily to an increase to from in the number of sales and administrative personnel  and other expenses related to the increase in the company s sales 
rent and leasehold expenses also increased primarily due to a substantial increase in the size of the company s australian facility 
in addition  fiscal included  of expenses associated with the grant of compensatory stock options and the establishment of a  reserve for estimated cost associated with the company s australian patent litigation 
research and development expenses 
research and development expenses increased in fiscal to million from million in fiscal  an increase of approximately  or 
as a percentage of net revenues  research and development expenses in fiscal decreased to from in fiscal the dollar increase in research and development expenses was due primarily to an increase in the average number of research and development employees over the period to approximately in fiscal from in fiscal this increase was also attributable to higher payments for consulting fees related to product development efforts 
other income 
other income increased in fiscal to  from  for fiscal  an increase of  or 
this increase was due primarily to the recognition of income for the receipt in december of an up front payment of  from a japanese company for the exclusive rights to market certain respiratory and related products in the japanese market that are under development by the company 
in addition  government grants for fiscal increased to  from  for fiscal as a result of government computer grant claims of  recognized by the company on receipt of a favorable australian government ruling in april income taxes 
the company s effective income tax rate for fiscal decreased to approximately from approximately for fiscal this decrease was primarily due to the company s use of net operating loss carryforward deductions available to offset united states income  and the additional research and development expenses in australia for which the company received a deduction for tax purposes 
recent accounting developments in march  the financial accounting standards board issued statement of financial accounting standards no 
sfas  accounting for the impairment of long lived assets and for long lived assets to be disposed of  effective for fiscal years beginning after december  sfas provides guidance for recognition and measurement of impairment of long lived assets  certain identifiable intangible assets and goodwill related both to assets to be held and used and assets to be disposed of 
the adoption of sfas is not expected to have a material effect on the company s financial position or results of operations 
in october  the financial accounting standards board issued sfas  accounting for stock based compensation  effective for fiscal years beginning after december  under the provisions of sfas  the company is encouraged  but not required  to measure compensation costs related to its employee stock compensation under the fair value method 
the company has elected not to recognize compensation expense under this methodology 
the company will adopt the proforma method of disclosure under sfas in fiscal year ended june  liquidity and capital resources as of june  and june   the company had cash and cash equivalents and marketable securities available for sale of approximately million and million  respectively 
the company s working capital approximated million and million  respectively  at june  and the increase in working capital balances reflects the net of the receipt of approximately million from the underwriter s exercise of their over allotment arising from the company s initial public offering less the cash used to fund the acquisition of two european distributors 
with the exception of the proceeds of the initial public offering  the company has predominantly financed its operations and capital expenditures through cash generated from operations and through sales of common stock 
during the fiscal years ended june  and  the company s operations generated approximately million and  respectively more cash than was used in operations  primarily as a result of continued increases in net revenues  offset in part by increases in accounts receivable levels and prepayments during however  cash and cash equivalents and marketable securities available for sale decreased to million at june  from million at june   a decrease of  after capital expenditures 
during fiscal and approximately  and  of cash was received from sales of common stock on exercise of outstanding options 
the company s june   balance sheet also reflects significant increases in the levels of inventory and accounts receivable over the levels reflected on the june   balance sheet as a result of the acquisition of priess medizintechnik and significant increases in the company s sales during the period 
the company s capital expenditures for the fiscal years ended june  and aggregated million and million  respectively 
the majority of these expenditures were for the purchase of the businesses of priess medizintechnik and premium medical for million  purchase of production tooling and equipment and  to a lesser extent  for the purchase of office furniture  computers and research and development equipment 
as a result the company s june  balance sheet reflects an increase in net property plant and equipment to approximately million at june   from million at june   an increase of approximately million 
the results of the company s international operations are affected by changes in exchange rates between currencies 
changes in exchange rates may negatively affect the company s consolidated net sales and gross profit margins from international operations 
the company is exposed to the risk that the dollar value equivalent of anticipated cash flows will be adversely affected by changes in foreign currency exchange rates 
the company manages this risk by entering into foreign currency option contracts 
in may  the australian federal government agreed to lend the company up to  over a six year term 
such loan bears no interest for the first three years and will bear interest at a rate of thereafter until maturity 
the first repayment of loan funds will commence in november the outstanding principal balance of such loan was  and  at june  and  respectively 

